Research Topics
Genomes and GenesSpecies | J KatadaSummaryAffiliation: Nagasaki University Country: Japan Publications
| Collaborators
|
Detail Information
Publications
Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarctionJun Katada
Pfizer KEIO Research Laboratory, Tokyo, Japan
Circulation 111:2157-64. 2005..The molecular basis underlying this Ang II-independent remodeling is unclear...
Significance of cyclooxygenase-2 induced via p38 mitogen-activated protein kinase in mechanical stimulus-induced peritoneal adhesion in miceJun Katada
KEIO Research Park 2N4, Keio University School of Medicine, Shinanomachi 35, Shinjuku ku, Tokyo 160 8582, Japan
J Pharmacol Exp Ther 313:286-92. 2005..In conclusion, COX-2, but not COX-1, plays a significant role in mechanical stimulus-induced peritoneal formation in the mouse cecum...
Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomasJun Katada
Department of Pharmacology, Kitasato University School of Medicine, Kanagawa, Japan
J Pharmacol Exp Ther 302:949-56. 2002..Furthermore, a chymase-Ang II-VEGF pathway may operate in granulation tissue as the primary mediator of angiogenesis...
Role of mast cell chymase in angiotensin-induced vascular contraction of hamster cheek pouch microvesselsJ Katada
Life Science Research Center, Advanced Technology Research Laboratories, Kawasaki, Japan
Eur J Pharmacol 379:63-72. 1999..Treatment of microvessels with 100 microg/ml compound 48/80 enhanced angiotensin I-induced vascular contraction response, suggesting the significance of mast cells as a source of cheek pouch chymase...
AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditionsJun Katada
Department of Pharmacology, Kitasato University School of Medicine, 1 15 1 Kitasato, Sagamihara, Kanagawa 228 8555, Japan
Br J Pharmacol 136:484-91. 2002..Such vasodilation counterbalances AT(1)-dependent vasoconstriction to regulate the vascular tone...
Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonistY Hayashi
Life Science Research Center, Advanced Technology Research Laboratories, Nippon Steel Corporation, Kawasaki, Japan
Bioorg Med Chem 6:355-64. 1998....
Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis modelM Muramatsu
Department of Pharmacology, Kitasato University School of Medicine, 1 15 1 Kitasato Sagamihara shi, Kanagawa 228 8555, Japan
J Biol Chem 275:5545-52. 2000..Our results may suggest a potential ability of chymase to promote angiogenesis through the local chymase-dependent and angiotensin-converting enzyme-dependent Ang II generating system in pathophysiological angiogenesis...
Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implantsM Majima
Department of Pharmacology, Kitasato University School of Medicine, Kitasato 1 15 1, Sagamihara, Kanagawa 228 8555, Japan
Br J Pharmacol 130:641-9. 2000..These results suggested that COX-2 may enhance bFGF-induced neovascularization in sponge granuloma by PG-mediated expression of VEGF, and that a COX-2 inhibitor would facilitate the management of conditions involving angiogenesis...
GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structureY Hayashi
Life Science Research Center, Advanced Technology Research Laboratories, Nippon Steel Corporation, 3 35 1 Ida, Nakahara ku, Kawasaki 211 0035, Japan
J Med Chem 41:2345-60. 1998..3-Substituted-2,2-dimethyl-beta-amino acid residues would serve as new and useful linear templates to restrict the conformational flexibility of peptidomimetics...
Antitumor activity of phenylahistin in vitro and in vivoK Kanoh
Life Science Research Center, Advanced Technology Research Laboratories, Nippon Steel Corporation, Kawasaki, Japan
Biosci Biotechnol Biochem 63:1130-3. 1999..8 x 10(-7) to 3.7 x 10(-6), while (+)-phenylahistin exhibited 33-100-fold less potent activity than (-)-phenylahistin did. (-)-Phenylahistin also showed antitumor activity against P388 leukemia and Lewis lung carcinoma cells in vivo...
